Diazyme Laboratories, Inc.

Home
United States
Poway, CA
Diazyme Laboratories, Inc.

Diazyme is a clinical chemistry reagent manufacturer that develops IVD assays for use on conventional open channel automated chemistry platforms.

04/09/2026

Supporting Better Diabetes Management with Advanced Testing

Effective diabetes management starts with accurate monitoring. Diazyme’s Diabetic Markers Panel includes advanced HbA1c, Glycated Serum Protein (GSP), and 1,5-AG assays, providing a comprehensive view of both long-term and short-term glucose control. These markers give healthcare providers the insights they need to optimize patient care and improve outcomes.

With innovative diagnostics, we’re making early detection and proactive diabetes care more accessible. Learn more about how our solutions support better health management.

Learn More about our Diabetic Markers: https://bit.ly/3A6C7SA

#1,5AG

04/08/2026

New ESC/EAS Guidelines on Lp(a)

Recent ESC/EAS guidance highlights the growing importance of lipoprotein(a) in cardiovascular risk assessment.

Key takeaways:
✅ Lp(a) is recognized as a risk-enhancing factor
✅ Measurement is recommended at least once in all adults
✅ Elevated levels can help identify hidden cardiovascular risk
✅ Supports more informed risk stratification and management decisions

As clinical guidelines continue to evolve, incorporating Lp(a) testing into routine evaluation is becoming increasingly important for early risk identification.

Diazyme’s Lp(a) assay supports laboratories with fast, reliable measurement and efficient workflow integration.

Learn more about Diazyme’s Lp(a) assay:
➡️https://www.diazyme.com/cardiovascular-markers/liprotein-lp-a-assay/

Read more on the new guidance:
➡️https://www.hcplive.com/view/lipid-management-in-special-populations-from-2026-dyslipidemia-guidelines

➡️https://www.patientcareonline.com/view/new-dyslipidemia-guidelines-emphasize-ldl-c-targets-lp-screening-pcps

04/06/2026

Spotlight on Gastro Health Panel: Supporting GI Health

Gastrointestinal disorders can significantly impact a patient’s quality of life, and assessing key biomarkers can help guide effective management. Diazyme’s Gastro Health Panel provides essential markers that support healthcare providers in evaluating gut health and making informed decisions for patient care.

By delivering reliable and efficient testing solutions, we’re helping to advance proactive approaches to digestive health.

Let’s emphasize the importance of gut health and proactive care this month!

04/01/2026

Irritable Bowel Syndrome (IBS) affects millions worldwide and diagnosing it can be a challenge. While no single test can diagnose IBS, Diazyme’s Gastro Health Panel can provide valuable insights into key gastrointestinal markers that help healthcare providers assess overall gut health.

By offering reliable and efficient testing solutions, we support healthcare providers in improving patient care.

Let’s raise awareness for IBS and the importance of gut health this month!

Start Prioritizing Gut Health Today: https://bit.ly/3YjCvVE

03/30/2026

Join the Diazyme Team

Be part of a team driven by innovation, collaboration, and a shared commitment to advancing diagnostic solutions.

Explore opportunities to grow your career and make an impact with Diazyme.

Explore our Career page ➡️ https://bit.ly/4stQ0j8

03/24/2026

Through American Diabetes Alert Day, we aim to raise awareness and work towards better methods of monitoring this global health challenge.

Diabetes is a metabolic disease that elevates blood sugar levels, leading to severe medical complications and causing millions of premature deaths each year. It has now become one of the leading causes of death worldwide.

At Diazyme, our expansive assay menu includes a unique collection of Diabetic Markers designed to equip clinical laboratories with the tools they need to better monitor and diagnose diabetic patients.

Explore our Diabetic Markers: https://bit.ly/3A6C7SA

03/19/2026

March is National Kidney Month, and at Diazyme Laboratories, we're proud to highlight the importance of renal markers in advancing kidney health!

Through our cutting-edge assays such as Enzymatic Creatinine and Cystatin C, we're dedicated to providing accurate and reliable testing options that empower healthcare professionals to monitor kidney health with precision and confidence.

Our comprehensive portfolio of renal markers enables clinicians to make informed decisions and tailor treatment strategies for patients with kidney-related conditions.

Join Diazyme Laboratories in recognizing National Kidney Month and advocating for kidney health!

Read More about our Renal and Pancreatic Markers Here:
https://bit.ly/4ioAmRa

03/16/2026

Why Monitor Kappa & Lambda Free Light Chains?

Normally, there's a balance between kappa and lambda free light chains in the bloodstream. However, in certain diseases, particularly plasma cell disorders such as multiple myeloma, there can be an imbalance in the production of these free light chains. This imbalance can lead to an excess of one type of light chain over the other, which is known as a kappa-lambda ratio imbalance.

This imbalance can be detected through laboratory tests, such as Diazyme’s Kappa and Lambda serum free light chain assays, which measures the levels of kappa and lambda free light chains in the blood. Monitoring the kappa-lambda ratio is important in the diagnosis and management of plasma cell disorders.

Learn More about these assays and to support healthcare providers in assessing disease progression and response to treatment.
https://bit.ly/4h7z6kn

03/12/2026

Chronic kidney disease (CKD) is a global health challenge, affecting around 850 million people worldwide.

Early detection and monitoring are crucial for managing the disease and improving patient outcomes. At Diazyme Laboratories, we are committed to empowering healthcare professionals with the tools they need to monitor kidney health with precision and confidence.

Our assays, such as Cystatin C and Enzymatic Creatinine, are designed to aid in the early diagnosis and effective management of CKD, offering a more accurate and reliable approach to kidney disease monitoring. With continuous advancements in biomarker research, we strive to provide the most cutting-edge solutions that support better care and improved quality of life for those affected by kidney disease.

Learn more: https://bit.ly/4ioAmRa

03/09/2026

Have you heard about the PLAC® test? It's a groundbreaking blood test that measures Lp-PLA2, a novel marker of vascular inflammation linked to cardiovascular disease.

Accurately assessing patients’ risk for CHD events remains a significant challenge in primary prevention.

The PLAC® Test for Lp-PLA2 Activity (PLAC® Activity) is the only FDA cleared test for Lp-PLA2 activity with a clinically validated cut-point. The test is analytically robust with performance that has been validated on multiple automated chemistry analyzers.

Why is this important? Because by detecting and monitoring this marker, we can better assess cardiovascular risk and tailor interventions for improved patient outcomes.

Learn how the PLAC® Test can enhance your diagnostic methods today! https://bit.ly/43EY9pJ

03/06/2026

🎥 Simplify Sample Collection for Gastro Health Assays!

Accurate sample collection is key to reliable diagnostic testing for gastrointestinal health, and Diazyme is here to make the process easier than ever. We are excited to announce the release of our Extraction Device Demonstration Videos, which guide users through the streamlined process of sample collection for calprotectin, lactoferrin, and pancreatic elastase assays.

These step-by-step videos ensure that your sample collection process is as simple, efficient, and accurate as possible, with consistent results every time. Whether you're testing for inflammation in the gut or digestive enzyme function, Diazyme’s Extraction Device makes it easier to get reliable, reproducible results.

Key Benefits of the Extraction Device:

Minimized Variability: Ensures accurate and consistent sample collection across all tests.

Ease of Use: Simple instructions for both Export (DZ202A-CLDF) and U.S. (DZ202A-ALP) devices.

Enhanced Lab Efficiency: Standardized protocols help improve workflow and reduce errors.

Our Extraction Devices are compatible with all three f***l assays (calprotectin, lactoferrin, and pancreatic elastase), providing a one-stop solution for gastrointestinal diagnostics. Watch the videos now to see how easy it is to gather samples for gastro health testing.

👉 Watch the videos:
For Export Use (DZ202A-CLDF): https://bit.ly/40Lr36w For U.S. Use (DZ202A-ALP): https://bit.ly/40Lr2Q0

03/04/2026

This March, Diazyme Laboratories proudly stands at the forefront of scientific advancement in the fight against myeloma during Myeloma Action Month!

What is Myeloma?
Myeloma is a complex hematological malignancy affecting plasma cells and presents unique challenges in diagnosis and monitoring.

Our Commitment:
Through our state-of-the-art assays, we're driving precision medicine forward, enabling early detection, accurate disease monitoring, and personalized treatment strategies. Diazyme is dedicated to the development of innovative diagnostic solutions for myeloma patients and healthcare providers.

Learn More about Diazyme’s Kappa & Lambda Free Light Chain Assays: https://bit.ly/4h7z6kn

Address

12889 Gregg Court
Poway, CA
92064

Website

http://www.diazyme.com/

Alerts

Be the first to know and let us send you an email when Diazyme Laboratories, Inc. posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Want your practice to be the top-listed Clinic in Poway?